Week in review: A new dermatology case study, and a new treatment for severe asthma
Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, April 8, to Friday, April 12, 2024), and click on each link to read and watch anything you may have missed.
1.) Young woman with tick bites presents with erythematous papules, headaches, and fatigue
A young woman with no significant past medical history returns from hiking with several white-spotted ticks and experiences erythematous papules, rashes, headaches, and fatigue. What’s the diagnosis?
Click here for the full case, differential diagnosis, and case diagnosis.
2.) FDA approves benralizumab for children aged 6 to 11 years with severe asthma
The FDA approval of benralizumab for patients ages 6 to 11 with asthma follows the conclusions of the phase 3 TATE study.
Click here for full FDA approval details.
3.) FDA approves dolutegravir/lamivudine to treat HIV infection in adolescents
The indication is approved for those with no antiretroviral (ARV) treatment history or to replace current ARV regimen in those, "are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable ARV regimen with no history of treatment failure and no known substitutions associated with resistance to the individual components of [dolutegravir/lamivudine]," ViiV stated.
Click here for full approval details.
4.) Does vitamin C among pregnant smokers improve airway function trajectory in offspring?
"Our findings provide evidence for a direct association between maternal smoking during pregnancy and wheeze occurrence," wrote the authors.
Click here for the full article.
5.) Does acetaminophen intake during pregnancy influence children’s risk of neurodevelopmental disorders?
A recently published study in JAMA sought to determine if there is a link between acetaminophen use during pregnancy and children’s risk of developing autism, ADHD, or intellectual disabilities.
